1. OLIVAMINE 10 ® Advanced Healing “Wound Care for Patients in Palliative Care /ICU and Geriatrics”

2. OLIVAMINE10 Advanced Care for At-Risk Compromised Skin Conditions USA Background Olivamine10 has been developed by a science based research company in the USA with 25 years of experience in compromised skin care science. The Olivamine10 formula has been sold in the USA for over 20 years & is the leading specialized wound care range in America Over a million doses each day in the US All Olivamine10 variants are specially formulated, based on small molecule technology of under 500 Daltons allowing deep penetration into the skin layers delivering a high potency antioxidant - Hydroxytyrosol & other nutrients for Skin Cell regeneration OLIVAMINE10 Olivamine10 has been tested to determine it's ORAC (Oxygen Radical Absorption Capacity) value as compared to fruits and vegetables known for their anti-oxidant activity. Brunswick Laboratories, Norton MA utilizing the COBRAS Fara II centrifugal analyzer. 8-15 Times More Anti-oxidants vs Fruits/ Vegetables Unique Deep Penetration Formula

4. SKIN SHIELD OLIVAMINE10 Advanced Care for At-Risk Compromised Skin Conditions Ideal for patients who currently have or are at risk of developing incontinence-associated dermatitis, diabetic skin complications, excoriation, diaper rash, fissures. 1% chlorhexidine digluconate helps suppress the growth of unwanted microorganisms and reducing the risk of wound infection. Prevents evaporation of moisture found in the skin tissue. Protects skin from irritation caused by external stimuli such as urine/feces. Silicone (Dimethicone) system provides breathable barrier that lasts even after up to 5 washings. Relieves dryness, especially for chapped/cracked skin abrasion & denuded skin.

5. OLIVAMINE 10 ® SKIN SHIELD OLIVAMINE10 SKIN SHIELD OFFERS LONG LASTING PROTECTION! NO NEED FOR FREQUENT RE-APPLICATION! Olivamine10 Skin Shield: This material is very thick and easily spread upon the skin. A large portion was absorbed slowly but still some on the skin surface after initial application. Product was extremely durable through 3 washes and if peak intensity is quantitatively accessed, the material would probably last at least one additional wash cycle. Hydration level in the skin was completely masked after initial application (an assumed increase In moisturization, less moisture from the skin is escaping). Water beaded on the surface of the test area up through the third wash.

6. PATHOGEN KILL RATE OLIVAMINE10 SKIN SHIELD Pathogen Kill Rates for Passed Criteria: Independent lab results indicated that Skin Shield has 99.9% decrease (3log) in the initial inoculums after 3 minutes of exposure time with no counts for growth for the following pathogens: Passed Criteria: Independent lab results indicated that Skin Shield has 99.9% decrease (3log) in the initial inoculums after 5-60minutes of exposure time with no counts for growth for the following pathogens: *Data on File

7. Perineal Region Breakdown Stage I & II Patient is 56 y/o white male Dx of CVA & R hemiplegia Incontinence of both bowel & bladder Methodology: Olivamine10 Skin Shield InitialAfter 3 Weeks

8. Reference: http://www.mccordresearch.com/sites/default/files/research/ApprovedColoradoRemedyStudy.pdf Findings A multi-brand skin care regimen was replaced by a single-brand skin care regimen of products containing Silicon-Based Dermal Nourishing Emollients (SBDNE). After this single-brand regimen was introduced into an existing pressure ulcer prevention program, the incidence of hospital-acquired pressure ulcers fell to 0 percent after 8 months. *After introducing Olivamine10, Pressure Ulcer Prevalence rates dropped from a peak of 30% to 0% helping achieve an estimated savings of $6,676.63 per patient.

9. How to use Olivamine10 Skin Shield: Clean the affected area. For best result, use non-cytotoxic Olivamine10 Cleansing Spray Apply Olivamine10 Skin Shield using a gentle touch. Do not rub-on to avoid causing mechanical stress to fragile or irritated skin. Apply generously once a day or as directed.

10. SKIN CLEANSER SPRAY Use for cleaning diabetic foot ulcers, pressure ulcers and other wounds. NO-RINSE FORMULA Specially formulated for cleansing damaged skin with a risk of infection. It helps to reduce strong odor of diabetic foot ulcers and other compromised skin. Preferred alternative to cytotoxic products like POVIDONE-IODINE since it kills gram negative bacteria but preserves gram positive organisms needed to promote the healing process Provides micro-nutrients, superior anti-oxidants, moisture & anti-inflammatory benefits that penetrates deep skin cells to assist the healing process Easy to use spray bottle allows for controlled delivery of cleanser directly to the wound site to limit dripping and wasted product. OLIVAMINE10 Advanced Care for At-Risk Compromised Skin Conditions

11. Efficacy Testing Recent changes in CMS (Center for Medicare and Medicaid Services) policies are designed to promote the reduction of hospital acquired infections (HAIs). To assure efficacy of Olivamine10 Skin Cleanser Spray, it has been tested against the most common microorganism in a health care setting. Effectiveness StandardOlivamine10 Skin Cleanser OLIVAMINE10 Skin Cleanser vs Microorganisms *Data on File

12. OLIVAMINE 10 ® CLEANSING LOTION Use ad a “Waterless Shower Lotion". Use to clean and deodorize skin complications. NO-RINSE FORMULA Contains a scientifically advanced blend of ingredients, including Olivamine10, designed to address multiple aspects of the wound healing process. Cleanse, moisturize, protect and nourish the skin with one no-rinse product. Coconut-based surfactants gently cleanse the skin while emollients like Safflowers seed oil restore moisture and reduce excessive trans-epithelial water loss (eTEWL). May be used to assist in the removal of zinc oxide products. Can be used to assist in debridement and the removal of excess bioburden. Olivamine10 provides antioxidant and nutrient support to nourish and protect developing skin cells. Delivers nutrients topically to poorly perfused tissues such as in peripheral artery disease and diabetes. Aids in debridement and to the removal of excess bioburden.